Walleye Trading
ABEO icon

Walleye Trading’s Abeona Therapeutics ABEO Stock Holding History

Walleye Trading’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8
Closed -$1K – 3954
2019
Q2 		$1K Sell
8
-392
-98% -$65.7K ﹤0.01% 3947
2019
Q1 		$74K Buy
+400
New +$71.5K ﹤0.01% 3585
2018
Q4 		– Sell
-160
Closed -$51K – 4537
2018
Q3 		$51K Sell
160
-184
-53% -$65.3K ﹤0.01% 4532
2018
Q2 		$138K Buy
+344
New +$150K ﹤0.01% 3874

Other funds holding ABEO

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Walleye Trading's ABEO Position: Q4 2019 in Review

Walleye Trading sold out of Abeona Therapeutics (ABEO) in Q4 2019, closing a stake of 1,609 shares — an estimated $91K sold.

Walleye Trading first reported a position in ABEO in Q3 2015 and held it in 3 quarters. The position peaked at $269K in Q2 2019. 87 funds tracked by Wall St. Rank hold ABEO as of Q4 2019.

  • Walleye Trading reported no remaining Abeona Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Walleye Trading sold 1,609 Abeona Therapeutics shares in Q4 2019, an estimated $91K.
  • Walleye Trading first reported a position in Abeona Therapeutics in Q3 2015 and held it in 3 quarters.
  • Walleye Trading's Abeona Therapeutics position peaked at $269K in Q2 2019.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2019.

Based on Walleye Trading's 13F filing for Q4 2019, filed 14 Feb 2020.